Grünenthal
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Germany · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
Zieglerstr. 6, Aachen, Nordrhein-Westfal...Phone Number
+49 2415690Website
www.grunenthal.comRevenue
$2 BillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
6
1
1
1
1
1
About Grünenthal
Grünenthal is a pharmaceutical company headquartered in Aachen, Germany, founded in 1946. The company specializes in developing and manufacturing pain medications and other pharmaceutical products. Grünenthal operates internationally with offices in Germany and subsidiaries across Europe, Latin America, the United States, and China. The company has a significant history in the pharmaceutical industry, including being the first to introduce penicillin to the German market after World War II. In 2016, Grünenthal expanded its operations through the acquisition of Thar Pharmaceuticals, further strengthening its position in the global pharmaceutical market.Explore more
Grünenthal Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Grünenthal your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Grünenthal, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Check if Grünenthal has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Grünenthal has new funding data
Click to see if Grünenthal had a recent Job posting/layoffs
Earning: See what the market has to say on Grünenthal recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Grünenthal is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Grünenthal
Product Launch: Get notified when Grünenthal launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
Grünenthal is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Grünenthal is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Grünenthal.
Grünenthal Tech Stack
A closer look at the technologies used by Grünenthal
See more technologies
Most Recent Scoops
Open Position
Open Position
Open Position
Hiring Plans
Grünenthal has more open roles in Information Technology than it has had at any time in the past 6 months with an increased focus on technologies like Veeva Systems, and experience with LeanIX, and Veeva Vault. Areas of expertise include: Application Integration Architecture, Data Modeling, SAP Administration, Data Science, Analytics, Data Privacy, and Standard SQL.
Hiring Plans
Open Position
Grünenthal News & Media
Grünenthal licenses exclusive South Korean rights to Qutenza® to BCWorld Pharm
AACHEN, Germany and YEOJU, South Korea, March 5, 2026 /PRNewswire/ -- Grünenthal, a global leader in pain management and related diseases, and BCWorld Pharm Co., Ltd. ("BCWP"), a specialty company actively expanding and diversifying its pain management portfolio through global open...Grünenthal takes full ownership of Grünenthal Meds, the joint venture established with Kyowa Kirin for its established medicines brands
Grünenthal acquired Kyowa Kirin International's 49% stake in 'Grünenthal Meds', a joint venture formed in 2023 to market the established medicines portfolio from Kyowa Kirin International. Through this acquisition, Grünenthal assumes the sole responsibility of a portfolio comprising 12...Grünenthal licenses exclusive Australian rights to Qutenza® to Clinect
AACHEN, Germany and VICTORIA, Australia, Feb. 24, 2026 /PRNewswire/ -- Grünenthal, a global leader in pain management and related diseases, and Clinect Pty Ltd ("Clinect"), an Australian based company focussed on supporting access to unique products, announced today that they have entered...Grünenthal's proprietary NaV 1.8 inhibitor enters clinical development
AACHEN, Germany, Feb. 18, 2026 /PRNewswire/ -- Grünenthal announced today that the first healthy volunteers have been enrolled in a Phase I trial of its voltage-gated sodium channel (NaV) 1.8 inhibitor. The orally administered investigational medicine aims to provide a non-opioid therapy...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Grünenthal
Sign Up For FreeTo access detailed company insights
Grünenthal is a pharmaceutical company headquartered in Aachen, Germany, founded in 1946. The company specializes in developing and manufacturing pain medications and other pharmaceutical products. Grünenthal operates internationally with offices in Germany and subsidiaries across Europe, Latin America, the United States, and China. The company has... Read More
